Company Filing History:
Years Active: 2008
Title: Paul Daniel Arnold: Innovator in Anxiety Disorder Diagnostics
Introduction
Paul Daniel Arnold is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of mental health through his innovative research and patented inventions. His work primarily focuses on diagnosing anxiety and mood disorders, which are critical areas in mental health.
Latest Patents
Arnold holds a patent for the SLC1A1 marker for anxiety disorder. This invention provides methods for diagnosing or identifying susceptibility to anxiety or mood disorders in subjects. One method involves testing a sample for the presence of a polymorphism in Intron 10 of the SLC1A1 gene. The presence of allele G or allele A of the A/G polymorphism rs301434 indicates susceptibility to an anxiety disorder. An alternate method tests for a polymorphism in the 3' untranslated region of the SLC1A1 gene, where the presence of allele C of C/G polymorphism rs3087879 also indicates susceptibility. Furthermore, a method is provided that tests for a haplotype in the SLC1A1 gene, where the combined presence of allele G of the A/G polymorphism rs301434 and allele C of the C/G polymorphism rs3087879 indicates susceptibility to a mood disorder. This patent highlights Arnold's commitment to advancing mental health diagnostics.
Career Highlights
Paul Daniel Arnold is affiliated with the Centre for Addiction and Mental Health, where he applies his expertise in mental health research. His work has been instrumental in developing methods that can lead to better diagnosis and treatment of anxiety disorders. His dedication to this field has made a significant impact on mental health care.
Collaborations
Arnold has collaborated with notable colleagues, including Margaret A. Richter and James Lowery Kennedy. These partnerships have fostered a collaborative environment that enhances research and innovation in mental health.
Conclusion
Paul Daniel Arnold is a pioneering inventor whose work in anxiety disorder diagnostics has the potential to transform mental health care. His contributions through patents and collaborations reflect his commitment to improving the lives of those affected by anxiety and mood disorders.